TY - JOUR
T1 - Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome
AU - Mathias, Andrew
AU - Moss, Arthur J.
AU - Lopes, Coeli M.
AU - Barsheshet, Alon
AU - McNitt, Scott
AU - Zareba, Wojciech
AU - Robinson, Jennifer L.
AU - Locati, Emanuela H.
AU - Ackerman, Michael J.
AU - Benhorin, Jesaia
AU - Kaufman, Elizabeth S.
AU - Platonov, Pyotr G.
AU - Qi, Ming
AU - Shimizu, Wataru
AU - Towbin, Jeffrey A.
AU - Michael Vincent, G.
AU - Wilde, Arthur A.M.
AU - Zhang, Li
AU - Goldenberg, Ilan
N1 - Funding Information:
This work was supported by research grants HL-33843 and HL-51618 from the National Institutes of Health, Bethesda, MD, and by a research grant from GeneDx to the Heart Research Follow-Up Program in support of the LQTS Registry. Dr Goldenberg receives research support from the Mirowski Foundation.
PY - 2013/5
Y1 - 2013/5
N2 - Background: Individual corrected QT interval (QTc) may vary widely among carriers of the same long QT syndrome (LQTS) mutation. Currently, neither the mechanism nor the implications of this variable penetrance are well understood. Objectives: To hypothesize that the assessment of QTc variance in patients with congenital LQTS who carry the same mutation provides incremental prognostic information on the patient-specific QTc. Methods: The study population comprised 1206 patients with LQTS with 95 different mutations and≥5 individuals who carry the same mutation. Multivariate Cox proportional hazards regression analysis was used to assess the effect of mutation-specific standard deviation of QTc (QTcSD) on the risk of cardiac events (comprising syncope, aborted cardiac arrest, and sudden cardiac death) from birth through age 40 years in the total population and by genotype. Results: Assessment of mutation-specific QTcSD showed large differences among carriers of the same mutations (median QTcSD 45 ms). Multivariate analysis showed that each 20 ms increment in QTcSD was associated with a significant 33% (P =.002) increase in the risk of cardiac events after adjustment for the patient-specific QTc duration and the family effect on QTc. The risk associated with QTcSD was pronounced among patients with long QT syndrome type 1 (hazard ratio 1.55 per 20 ms increment; P<.001), whereas among patients with long QT syndrome type 2, the risk associated with QTcSD was not statistically significant (hazard ratio 0.99; P =.95; P value for QTcSD-by-genotype interaction =.002). Conclusions: Our findings suggest that mutations with a wider variation in QTc duration are associated with increased risk of cardiac events. These findings appear to be genotype-specific, with a pronounced effect among patients with the long QT syndrome type 1 genotype.
AB - Background: Individual corrected QT interval (QTc) may vary widely among carriers of the same long QT syndrome (LQTS) mutation. Currently, neither the mechanism nor the implications of this variable penetrance are well understood. Objectives: To hypothesize that the assessment of QTc variance in patients with congenital LQTS who carry the same mutation provides incremental prognostic information on the patient-specific QTc. Methods: The study population comprised 1206 patients with LQTS with 95 different mutations and≥5 individuals who carry the same mutation. Multivariate Cox proportional hazards regression analysis was used to assess the effect of mutation-specific standard deviation of QTc (QTcSD) on the risk of cardiac events (comprising syncope, aborted cardiac arrest, and sudden cardiac death) from birth through age 40 years in the total population and by genotype. Results: Assessment of mutation-specific QTcSD showed large differences among carriers of the same mutations (median QTcSD 45 ms). Multivariate analysis showed that each 20 ms increment in QTcSD was associated with a significant 33% (P =.002) increase in the risk of cardiac events after adjustment for the patient-specific QTc duration and the family effect on QTc. The risk associated with QTcSD was pronounced among patients with long QT syndrome type 1 (hazard ratio 1.55 per 20 ms increment; P<.001), whereas among patients with long QT syndrome type 2, the risk associated with QTcSD was not statistically significant (hazard ratio 0.99; P =.95; P value for QTcSD-by-genotype interaction =.002). Conclusions: Our findings suggest that mutations with a wider variation in QTc duration are associated with increased risk of cardiac events. These findings appear to be genotype-specific, with a pronounced effect among patients with the long QT syndrome type 1 genotype.
KW - Corrected QT interval
KW - Long QT syndrome
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=84876547836&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2013.01.032
DO - 10.1016/j.hrthm.2013.01.032
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23369741
AN - SCOPUS:84876547836
SN - 1547-5271
VL - 10
SP - 720
EP - 725
JO - Heart Rhythm
JF - Heart Rhythm
IS - 5
ER -